Anbio Biotechnology Class A Ordinary Shares Stock Forecast

Sell candidate since Jun 03, 2026

The Anbio Biotechnology Class A Ordinary stock price fell by -11.24% on the last day (Wednesday, 3rd Jun 2026) from $32.12 to $28.51. During the last trading day the stock fluctuated 18.59% from a day low at $26.49 to a day high of $31.42. The price has fallen in 6 of the last 10 days and is down by -11.84% for this period. Volume has increased on the last day by 29 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 43 thousand shares were bought and sold for approximately $1.22 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $27.11 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 39.37% during the next 3 months and, with a 90% probability hold a price between $37.79 and $48.88 at the end of this 3-month period.

NNNN Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Anbio Biotechnology Class A Ordinary stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $32.21 and $28.75. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -17.22%. Further fall is indicated until a new bottom pivot has been found. Anbio Biotechnology Class A Ordinary gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Anbio Biotechnology Class A Ordinary stock

Anbio Biotechnology Class A Ordinary finds support from accumulated volume at $27.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $4.93 between high and low, or 18.59%. For the last week, the stock has had daily average volatility of 11.33%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NNNN) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Anbio Biotechnology Class A Ordinary Shares to open at $28.81, and during the day (based on 14 day Average True Range), to move between $26.91 and $30.11, which gives a possible trading interval of +/-$3.20 (+/-11.89%) up or down from last closing price. If Anbio Biotechnology Class A Ordinary Shares takes out the full calculated possible swing range there will be an estimated 11.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $28.84 (1.16%) than the support at $27.15 (4.77%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Anbio Biotechnology Class A Ordinary Shares stock A Buy?

The Anbio Biotechnology Class A Ordinary stock holds several negative signals and despite the positive trend, we believe Anbio Biotechnology Class A Ordinary will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -4.900 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $28.81 ( 1.03%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk